PRAX
Praxis Precision Medicines, Inc.
Stock
$295.51+8.60 (+3.00%)Close Oct 2, 2026
Income statement
| Line | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $8.6M | $2.4M | $0 |
| R&D | $267M | $152M | $87M | $155M |
| Operating income | −$326M | −$200M | −$126M | −$215M |
| Non-operating income | $23M | $17M | $3.4M | — |
| Pretax income | −$303M | −$183M | −$123M | — |
| Taxes | $471K | $76K | $264K | — |
| Net income | −$303M | −$183M | −$123M | −$214M |
| Diluted EPS | −$13.48 | −$10.21 | −$18.69 | −$69.65 |
| Diluted shares | 22.5M | 17.9M | 6.6M | 3.1M |
| Revenue growth | −100.0% | +249.5% | — | — |
| Operating margin | — | −2,340.3% | −5,164.4% | — |
| Net margin | — | −2,137.5% | −5,037.9% | — |